Pharmacokinetics
Study Guide

Pharmacokinetics

by Anonymous · 2026-06-15

Drug pharmacokinetics: absorption, distribution, metabolism, excretion

5 chapters 4,764 words ~19 min read English 161 reads

Read the first chapter

The whole of chapter one, free. About 5 min. Turn the pages with the arrows, your keyboard, or a swipe.

Chapter 1

Absorption: Bioavailability and Rate

Key Concepts

This chapter covers how drug absorption and bioavailability control onset of effect (when plasma drug levels rise enough to produce pharmacological action). For exams, you need both the rate (how fast levels rise) and the extent (how much drug reaches systemic circulation).

Core ideas you must know

• Onset depends on absorption rate + distribution + elimination

• Faster absorption → earlier rise in plasma concentration → earlier onset (assuming target exposure is reached).

• Bioavailability (F) determines the extent of exposure

• If F is low, systemic exposure is low even if absorption is fast.

• Route matters

• IV: F = 1 (100% reaches systemic circulation immediately).

• Oral: F < 1 due to incomplete absorption and first-pass metabolism.

• Absorption rate is influenced by drug + formulation + physiology

• Examples: gastric emptying, intestinal transit, solubility, permeability, surface area, food effects.

• Absorption extent is influenced by first-pass effect and incomplete uptake

• First-pass metabolism in gut wall/liver reduces F.

• Concentration-time shape links to PK

• Faster absorption often gives a steeper early rise in concentration-time curve.

Before you continue

• Can you explain, in one paragraph, why an oral dose can have a delayed or weaker onset compared with the same dose given IV?

Key Terms

Absorption - Movement of drug from the administration site into systemic circulation.

Bioavailability (F) - Fraction of the administered dose that reaches systemic circulation unchanged (compared with IV).

First-pass metabolism - Drug metabolism in gut wall and/or liver before systemic circulation (reduces F for oral dosing).

Absorption rate - Speed at which drug enters systemic circulation (affects onset and early plasma levels).

Onset of action - Time until drug concentration at the site of action reaches the effective level.

AUC (Area Under the Curve) - Overall systemic exposure; lower F generally gives lower AUC after non-IV dosing.

Permeability - Ability of drug to cross biological membranes (limits absorption for polar drugs).

Active Recall

Absorption - __________________________________________________

__________________________________________________

__________________________________________________

Bioavailability (F) - __________________________________________________

__________________________________________________

__________________________________________________

First-pass metabolism - __________________________________________________

__________________________________________________

__________________________________________________

Absorption rate - __________________________________________________

__________________________________________________

__________________________________________________

Onset of action - __________________________________________________

__________________________________________________

__________________________________________________

AUC (Area Under the Curve) - __________________________________________________

__________________________________________________

__________________________________________________

Permeability - __________________________________________________

__________________________________________________

__________________________________________________

Worked Examples

Example 1 (Straightforward): IV vs Oral onset

A 50 mg dose is given IV and oral (same drug). Assume elimination is identical and the oral route has F = 0.5.

• IV: F = 1, so systemic exposure is higher immediately.

• Oral: only 50% reaches systemic circulation unchanged.

• Onset: oral onset is often delayed because drug must be absorbed first, and exposure may be lower, potentially delaying reaching the effective concentration.

Now you try

A 100 mg oral dose has F = 0.25. The same drug is given IV at 50 mg.

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

Example 2 (Rate vs extent): formulation changes absorption rate

Two oral formulations deliver the same dose and have the same F. Formulation A absorbs faster than B.

• Same F → similar overall AUC (extent).

• Faster absorption rate → earlier rise in plasma concentration.

• Onset: A should show earlier onset than B even though total exposure is similar.

Now you try

Formulation A and B have the same F, but A has faster absorption. Predict which one shows earlier onset and why.

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

Example 3 (More complex): first-pass metabolism reduces extent

A drug is orally administered. Gut wall/liver metabolism reduces F. Another drug of the same dose shows minimal first-pass effect.

• High first-pass effect → lower F → lower systemic AUC.

• Lower AUC can mean the effective concentration is reached later or not at all (depending on required exposure).

• Absorption rate might be similar, but onset can still differ due to reduced extent.

Now you try

Drug X has strong first-pass metabolism; Drug Y has weak first-pass metabolism. If both are absorbed at the same rate, which is more likely to have a lower AUC after oral dosing, and how can that affect onset?

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

Practice Questions

• (Easy) Define bioavailability (F) and state its value for IV dosing.

__________________________________________________

__________________________________________________

__________________________________________________

• (Easy) Give two reasons why oral dosing often has different onset compared with IV dosing.

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

• (Medium) Explain how first-pass metabolism affects absorption extent and what marker of exposure is likely to change (mention AUC).

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

• (Medium) A formulation changes the absorption rate but not the overall bioavailability. What happens to onset and AUC?

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

• (Hard) A drug shows delayed onset after oral administration, but the final plasma

concentration (AUC) is unchanged compared with a reference. Explain two possible causes and link each cause to onset.

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

• (Hard) Compare the effect of (i) reduced gastric emptying and (ii) higher intestinal permeability on onset and extent. State what changes in rate vs F/AUC for each.

__________________________________________________

__________________________________________________

__________________________________________________

__________________________________________________

Answer Key

• Bioavailability (F) is the fraction of the administered dose that reaches the systemic circulation; for IV dosing, F = 1 (100%).

• Examples: No absorption step for IV (immediate systemic availability); oral has absorption + possible first-pass metabolism (gut/liver reduce extent and can delay onset).

• First-pass metabolism reduces extent (lower F ), so AUC decreases; onset may be delayed because systemic concentrations rise less and may take longer to reach effective levels.

• If F is unchanged, AUC stays the same but onset changes: faster absorption → earlier onset; slower absorption → later onset.

• Possible causes: delayed gastric emptying or enteric coating delay the absorption rate (onset later) while total absorbed amount can remain similar (AUC unchanged). Another cause is rate-limiting absorption step that affects timing but not overall fraction absorbed.

• (i) Reduced gastric emptying slows delivery to small intestine → slower rate → later onset, extent may be similar (AUC often similar if absorption completes). (ii) Higher intestinal permeability increases absorption rate (and potentially F) → earlier onset; extent may increase (higher AUC) if permeability limits absorption previously.

Exam Tips & Common Mistakes

• Don’t mix up onset (rate/early rise) with extent (overall exposure measured by AUC).

• If the question mentions “same AUC”, don’t propose changes that alter F; instead focus on absorption rate (formulation, GI transit, dissolution).

• When you see oral vs IV, remember IV bypasses absorption and first-pass - so differences are mainly F and absorption rate.

• Avoid vague answers like “it absorbs better”; specify whether it changes rate (when Cmax/effective level is reached) or extent (AUC/F).

• Examiner phrasing: for 8-12 marks, use two linked causes (rate factor + extent/first-pass factor) and state the expected direction for onset and AUC.

Quick marker-focused phrases to include

• “This affects the absorption rate and therefore the onset

End of chapter one. 4 more chapters in the full book.

1 / 7

Swipe or use the arrows to turn the page

What's inside: 5 chapters

  1. 1. Absorption: Bioavailability and Rate
  2. 2. Distribution: Volume of Distribution
  3. 3. Metabolism: Hepatic Clearance Pathways
  4. 4. Excretion: Renal Filtration and Clearance
  5. 5. Half-life, Clearance, and Steady State

About this book

"Pharmacokinetics" is a study guide book by Anonymous with 5 chapters and approximately 4,764 words. Drug pharmacokinetics: absorption, distribution, metabolism, excretion.

This book was created using Inkfluence AI, an AI-powered book generation platform that helps authors write, design, and publish complete books. It was made with the Study Guide Generator.

Frequently Asked Questions

What is "Pharmacokinetics" about?

Drug pharmacokinetics: absorption, distribution, metabolism, excretion

How many chapters are in "Pharmacokinetics"?

The book contains 5 chapters and approximately 4,764 words. Topics covered include Absorption: Bioavailability and Rate, Distribution: Volume of Distribution, Metabolism: Hepatic Clearance Pathways, Excretion: Renal Filtration and Clearance, and more.

Who wrote "Pharmacokinetics"?

This book was written by Anonymous and created using Inkfluence AI, an AI book generation platform that helps authors write, design, and publish books.

How can I create a similar study guide book?

You can create your own study guide book using Inkfluence AI. Describe your idea, choose your style, and the AI writes the full book for you. It's free to start.

Write your own study guide book with AI

Describe your idea and Inkfluence writes the whole thing. Free to start.

Start writing

Created with Inkfluence AI